期刊文献+

慢性丙型肝炎患者中丙型肝炎病毒准种变异研究进展 被引量:2

Quasispecies Variability Among Chronic Hepatitis C Patients
下载PDF
导出
摘要 丙型肝炎病毒(HCV)具有较高的变异性,通常以准种的形式分布在感染者的体内,病毒容易逃离机体的免疫监控,因而无法被有效地清除,导致机体很难控制其感染的发展,故易转变成慢性肝炎。HCV准种变异在宿主体内的持续存在对病毒感染的控制、抗病毒药物和疫苗的发展都是一个巨大的挑战。我们重点阐述近年来关于HCV准种变异及其与慢性丙型肝炎患者的机体免疫、疾病进展、治疗效果之间关系的研究进展。 Hepatitis C virus(HCV) has high variability and circulates in vivo as a quasispecies leading to chronic hepatitis C infection which is difficult to control. HCV easily lead to virus escape from immune surveillance, and thus can not be effectively removed. The large reservoir of variants provided by the quasispeeies represents a great challenge for the control of HCV infeetion and has important biologic implication for viral persistence, host cell tropism, antiviral drug resistance, and development of an HCV vaccine. In this review we discussed the relevance of the HCV quasispecies variability to immune response, disease progression and response to therapy.
出处 《生物技术通讯》 CAS 2013年第6期865-870,共6页 Letters in Biotechnology
基金 传染病防治重大专项(2009ZX1004-715 2013ZX10004-601)
关键词 丙型肝炎病毒 变异 准种 hepatitis C virus mutation quasispecies
  • 相关文献

参考文献1

二级参考文献10

  • 1Lindenbach BD,,Thiel HJ,and Rice CM.Flaviviridae: the viruses and their replication[].Fields Virology.2007
  • 2Sung VM,Shimodaira S,Doughty AL,Picchio GR,Can H,Yen TS,Lindsay KL,Levine AM,Lai MM.Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection[].J Virol.2003
  • 3Parren PW,Burton DR.The antiviral activity of antibodies in vitro and in vivo[].Advances in Immunology.2001
  • 4Hangartner L,Zinkernagel RM,Hengartner H.Antiviral antibody responses: the two extremes of a wide spectrum[].Nature Reviews Immunology.2006
  • 5Barth H,Schafer C,Adah MI,Zhang F,Linhardt RJ,Toyoda H,Kinoshita-Toyoda A,Toida T,Van Kuppevelt TH,Depla E,Von Weizsacker F,Blum HE,Baumert TF.Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate[].J Biol Chem.2003
  • 6Rosa D,Campagnoli S,Moretto C,Guenzi E,Cousens L,Chin M,Dong C,Weiner AJ,Lau JY,Choo QL,Chien D,Pileri P,Houghton M,Abrignani S.A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells[].Proc Natl Acad Sci USA.1996
  • 7Barth H,Cerino R,Arcuri M,Hoffmann M,Schurmann P,Adah MI,Gissler B,Zhao X,Ghisetti V,Lavezzo B,Blum HE,von Weizsacker F,Vitelli A,Scarselli E,Baumert TF.Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes[].J Virol.2005
  • 8Triyatni M,Saunier B,Maruvada P,Davis AR,Ulianich L,Heller T,Patel A,Kohn LD,Liang TJ.Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry[].J Virol.2002
  • 9Barth H,Schnober EK,Zhang F,Linhardt RJ,Depla E,Boson B,Cosset FL,Patel AH,Blum HE,Baumert TF.Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction[].J Virol.2006
  • 10Bartosch B,Bukh J,Meunier JC,Granier C,Engle RE,Blackwelder WC,Emerson SU,Cosset FL,Purcell RH.In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes[].Proc Natl Acad Sci USA.2003

共引文献2

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部